T. Deng

发表

Clinical outcome of 31 patients with primary malignant melanoma of the vagina

He Huang, Jihong Liu, T. Wan, 2013, Journal of gynecologic oncology.

ITGB2 as a Novel Biomarker Correlating With Prognosis and Immune Infiltrates in Ovarian Cancer

He Huang, Jihong Liu, T. Wan, 2021 .

Clinicopathological and prognostic significance of GLUT1 in breast cancer

Yu Deng, Junying Liu, T. Deng, 2018, Medicine.

The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer

Shumei Yan, He Huang, Jihong Liu, 2017, Journal of Cancer.

Comparative analysis of quality of life for three different adjuvant treatment modality in early stage cervical cancer: an analysis from STARS study

Yong-wen Huang, He Huang, Jihong Liu, 2021, Gynecologic Oncology.

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer

Lan Yu, He Huang, Jihong Liu, 2021, Frontiers in Immunology.

Comparison of platinum monotherapy with concurrent chemoradiation therapy versus platinum-based dual drug therapy with concurrent chemoradiation therapy for locally advanced cervical cancer: a systematic review and meta-analysis

Yuan-Jui Yu, T. Deng, Shequn Gu, 2022, Infectious agents and cancer.

The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer

He Huang, Jihong Liu, T. Wan, 2021, Journal of gynecologic oncology.

Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery

Jihong Liu, Yanling Feng, Qidan Huang, 2015, Journal of gynecologic oncology.

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer

Jihong Liu, Yanling Feng, Yun Zhou, 2023, Diagnostics.

Individualized Treatment of Patients With Early-Stage Epithelial Ovarian Cancer After Incomplete Initial Surgery

Y. Xiong, Yong-wen Huang, He Huang, 2015, International Journal of Gynecologic Cancer.